Changeflow GovPing Pharma & Drug Safety Patent Application: Dichrostachys glomerata for...
Routine Notice Added Draft

Patent Application: Dichrostachys glomerata for Anxiety and Stress Reduction

Email

Summary

The USPTO has published a patent application (US20260083793A1) detailing methods and compositions using Dichrostachys glomerata to reduce anxiety, stress, and food cravings, while improving mood and energy. The application was filed on September 25, 2024, by inventor Shil Kothari.

What changed

This document is a patent application (US20260083793A1) filed with the USPTO by Shil Kothari. It describes methods and compositions utilizing Dichrostachys glomerata, specifically fruit pods in oral dosage forms (pill, capsule, liquid, lozenge, or tablet), aimed at reducing anxiety, food cravings, and stress in mammals. The application also claims benefits such as improved mood, physical and mental health, energy, and overall happiness.

As this is a patent application, it does not impose immediate regulatory obligations on businesses. However, it signals potential future developments in the therapeutics sector related to natural compounds for mental well-being. Companies in the pharmaceutical or dietary supplement industries may wish to monitor the progress of this patent application and similar filings for competitive intelligence and potential licensing opportunities.

Source document (simplified)

← USPTO Patent Applications

METHODS AND COMPOSITIONS USING DICHROSTACHYS GLOMERATA TO REDUCE ANXIETY, FOOD CRAVINGS AND STRESS AND IMPROVE MOOD, PHYSICAL HEALTH, MENTAL HEALTH, ENERGY AND HAPPINESS IN A MAMMAL

Application US20260083793A1 Kind: A1 Mar 26, 2026

Inventors

Shil Kothari

Abstract

Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, stress and improve mood, physical health, mental health, energy and happiness and improve other quality of life factors in one or more mammals, are provided. In one embodiment, a composition for reducing stress in a mammal is provided, wherein the composition comprises an effective amount of Dichrostachys glomerata fruit pods provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.

CPC Classifications

A61K 36/48 A61K 9/0053 A61P 25/22

Filing Date

2024-09-25

Application No.

18896884

View original document →

Classification

Agency
USPTO
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083793A1

Who this affects

Applies to
Consumers Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Development Dietary Supplements
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Public Health Consumer Protection

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Therapeutics (A61P) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.